CRL-2265 CEM/C1 人急性**細胞白血病細胞

]資料

點擊看大圖

如果您對該產品感興趣的話,可以

產品名稱: CRL-2265 CEM/C1 人急性**細胞白血病細胞
產品型號: CRL-2265
產品廠商: 美國標準生物品收藏中心（ATCC）
產品文檔: 無相關文檔

簡單介紹

CRL-2265 CEM/C1 人急性**細胞白血病細胞， ATCC 細胞|細胞系|細胞株|腫瘤細胞|細胞；細胞庫管理規范，提供的細胞株背景清楚，提供參考文獻和培養條件！

CRL-2265 CEM/C1 人急性**細胞白血病細胞的詳細介紹

CRL-2265 CEM/C1 人急性**細胞白血病細胞

ATCC^® Number:

CRL-2265?

Price:

Designations:	CEM/C1
Depositors:	WG Harker
Biosafety Level:	1
Shipped:	frozen
Medium & Serum:	See Propagation
Growth Properties:	suspension
Organism:	Homo sapiens
Morphology:	lymphoblast
Source:	Organ: peripheral blood Disease: acute lymphoblastic leukemia Cell Type: T lymphoblast;
Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age:	4 years
Gender:	female
Ethnicity:	Caucasian
Comments:	CEM/C1 is a camptothecin (CPT) resistant derivative of the human T cell leukemia cell line CCRF-CEM (see ATCC CCL-119). The cell line was selected and subcloned in 1991 for resistance to CPT. The cells exhibit cross resistance to both the water soluble (topotecan) and water insoluble (9-amino-CPT and 10,11-methylenedioxy-CPT) analogs of CPT. CEM/C1 cells are approximately 31 fold less sensitive to CPT than the parental CEM cells. CEM/C1 cells display atypical multidrug resistance (MDR) and altered topoisomerase I catalytic activity. Resistance to CPT is stable for up to six months.
Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Temperature: 37.0°C
Subculturing:	Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of medium. Establish new cultures at 2 X 10 exp5 viable cells/ml and maintain between 1 X 10 exp5 and 2 X 10 exp6.
Preservation:	culture medium 95%; DMSO, 5%
Doubling Time:	26 hrs
Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001 recommended serum:ATCC 30-2020 parental cell line:ATCC CCL-119
References:	22339: Kapoor R, et al. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin. Oncol. Res. 7: 83-95, 1995. PubMed: 7579731 23117: Fujimori A, et al. Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Res. 55: 1339-1346, 1995. PubMed: 7882333

產品留言

標題

聯系人

聯系電話

內容

驗證碼

點擊換一張

注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發送信息!
2.如有必要,請您留下您的詳細聯系方式!

相關產品

3T3D 人骨髓瘤細胞 3T3D 人骨髓瘤細胞

HTB-120 NCI-H128 人肺小細胞肺癌細胞 HTB 120 NCI H128

HTB-119 NCI-H69 [H69]人肺小細胞肺癌細胞 HTB-119

HS77 人肺小細胞肺癌細胞 HS77

D6 人肺腺癌細胞 D6

聯系我們



 	電      話：021-35080510

 手       機: 15000266580（微信同步）

 菌種Q Q ： 316826860

 細胞Q Q ：1784382136

  
 

 
 	菌種Q Q:1623059823 
 
 Email：xiangfbio@163.com

產品搜索

細胞系，ATCC細胞，ATCC菌種，細胞系目錄，ATCC，鼠傷寒沙門氏菌，atcc細胞庫，人**瘤細胞，人食管癌細胞，ATCC 19404，ATCC 25922，ATCC 19146，微生物菌種，細胞株，標準菌株，ATCC中國，atcc上海代理，CMCC 菌株，ATCC菌株，細胞目錄，質控菌株，腫瘤細胞株，乳腺癌細胞系，人肝癌細胞系

產品目錄